No Abstract available for this article.doi:10.1007/s40014-012-1588-8Mohindru, PoojaKhanna, RajeshBhatia, S. S.Springer Healthcare CommunicationsSpringer Healthcare News
The Next Wave in Biliary Tract Cancers: Leveraging Immunogenicity to Optimize Patient Outcomes in an Evolving Treatment Landscape View More The Evolving Tool Box in Advanced HR+/HER2– Breast Cancer: What You Need to Know About Next-Generation SERDs, PI3K/AKT, ADCs, CDK4/6 and Beyond… View...
Colorectal cancer, commonly known as colon cancer or large intestine cancer, originates from the tissues of the colon (the longest part of the large intestine) or rectum (the last several inches of the large intestine before the anus). How Common is Colorectal Cancer? Colorectal cancer is ...
The gold standard for diagnosis of colorectal cancer is via colonoscopy with biopsy. If a colonoscopy is not suitable for the patient, such as from frailty, co-morbidities, or intolerance, CT colonography can be performed for initial diagnosis (however, if any abnormalities are found, further tre...
https://www.cdc.gov/cancer/colorectal/basic_info/screening/tests.htm 12. Knudsen AB, Rutter CM, Peterse EF, et al. Colorectal Cancer Screening: A Decision Analysis for the US Preventive Services Task Force. Agency for Healthcare Research and Quality; 2021. AHRQ publication 20-...
What Is the Patient Population Under Consideration for Screening for Colorectal Cancer? This USPSTF recommendation applies to adults aged 45 years or older who do not have symptoms of colorectal cancer. It does not apply to people who are at higher risk of colorectal cancer, such as those who ...
Morris A. M. (2006). Patient-centered outcomes after therapy for colorectal cancer . Surg. Oncol. Clin. N. Am. 15 , 195–211,viii.10.1016/j.soc.2005.09.005 [ Cross Ref ]Morris AM. Patient-centered outcomes after therapy for colorectal cancer. Surg Oncol Clin N Am 2006;15:195-211, ...
FDA Approval of FRUZAQLA™ (fruquintinib) for Previously Treated Metastatic Colorectal Cancer# Takeda Receives U.S. FDA Approval of FRUZAQLA™ (fruquintinib) for Previously Treated Metastatic Colorectal Cancer November 8, 2023 Share FRUZAQLA is the First ...
Fernandes DC, Nelson D, Siriwardena AN, Law G, Andreyev HJN (2023) Understanding colorectal cancer patient follow-up: a qualitative interview study. Support Care Cancer 31(11):634 Article PubMed Google Scholar Korstjens, I., & Moser, A. (2018). Series: Practical guidance to qualitative ...
Electronic Patient Messages to Promote Colorectal Cancer Screening.The article discusses a randomized controlled trial of the impact of electronic patient messages (EPM) and personalized risk assessments (PRA), which were delivered via an integrated personal health record, on colorectal cancer screening (...